About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Exisulind Prior to Radical Prostatectomy | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 2NCT00166478

Exisulind Prior to Radical Prostatectomy

This trial will compare no treatment to exisulind therapy. Patients enrolled on the treatment arm will begin treatment 4 weeks prior to the scheduled date of surgical removal of the prostate and will ...

Lead sponsor: Mayo Clinic•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Mayo Clinic

Collaborators

National Cancer Institute (NCI)

Age

40 - No limit years

Sex

MALE

Healthy Volunteers

No

Inclusion Criteria

•Males 40 years of age and older with prostate cancer who are scheduled to undergo surgical removal of the prostate at Mayo Clinic Rochester, Mayo Clinic Jacksonville, or Mayo Clinic Arizona may be eligible for this protocol.

Related studies

Low to Moderate Load Power Training for Men With Metastatic Prostate Cancer.

NCT07572760 · Prostatic Neoplasms

RECRUITINGPhase 1/2

Gedatolisib in Combination With Darolutamide in Metastatic Castration-Resistant Prostate Cancer

NCT06190899 · mCRPC (Metastatic Castration-resistant Prostate Cancer), Genital Diseases, Male, and more

RECRUITINGPhase 3

A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer

NCT07225946 · Prostatic Neoplasms, Castration-Resistant

Prostate Adaptive Radiation Therapy

NCT06547398 · Prostatic Neoplasms

RECRUITINGPhase 1/2

64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)

NCT04868604 · Prostatic Neoplasms, Castration-Resistant

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 28, 2010Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE2

Enrollment130

Start dateApr 2002

Last updatedJan 28, 2010

Condition

Prostatic Neoplasms

Locations shown

Mayo Clinic

Rochester, Minnesota

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 28, 2010Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions